153 related articles for article (PubMed ID: 37680228)
1. NHERF1/EBP50 immunoexpression in renal cell carcinomas and oncocytomas with ultrastructural analysis of clear cell renal cell carcinoma.
Aksionau A; Silva RA; Hartman B; Flowers A
Transl Androl Urol; 2023 Aug; 12(8):1283-1295. PubMed ID: 37680228
[TBL] [Abstract][Full Text] [Related]
2. Nuclear expression of NHERF1/EBP50 in Clear Cell Renal Cell Carcinoma.
Lema BE; Patricio GM; Kreimann EL
Acta Histochem; 2021 Jul; 123(5):151717. PubMed ID: 33965858
[TBL] [Abstract][Full Text] [Related]
3. NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.
Georgescu MM; Mobley BC; Orr BA; Shang P; Lehman NL; Zhu X; O'Neill TJ; Rajaram V; Hatanpaa KJ; Timmons CF; Raisanen JM
Acta Neuropathol Commun; 2016 May; 4(1):55. PubMed ID: 27229317
[TBL] [Abstract][Full Text] [Related]
4. Epithelial differentiation with microlumen formation in meningioma: diagnostic utility of NHERF1/EBP50 immunohistochemistry.
Georgescu MM; Olar A; Mobley BC; Faust PL; Raisanen JM
Oncotarget; 2018 Jun; 9(47):28652-28665. PubMed ID: 29983887
[TBL] [Abstract][Full Text] [Related]
5. Roles of NHERF1/EBP50 in cancer.
Georgescu MM; Morales FC; Molina JR; Hayashi Y
Curr Mol Med; 2008 Sep; 8(6):459-68. PubMed ID: 18781953
[TBL] [Abstract][Full Text] [Related]
6. A Comparative Immunohistochemical Study of Epithelial Membrane Antigen and NHERF1/EBP50 in the Diagnosis of Ependymomas.
Nambirajan A; Sharma MC; Rajeshwari M; Kakkar A; Suri V; Sarkar C
Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):71-78. PubMed ID: 27753657
[TBL] [Abstract][Full Text] [Related]
7. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
8. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
9. The NHERF1 PDZ1 domain and IRBIT interact and mediate the activation of Na+/H+ exchanger 3 by ANG II.
He P; Zhao L; No YR; Karvar S; Yun CC
Am J Physiol Renal Physiol; 2016 Aug; 311(2):F343-51. PubMed ID: 27279487
[TBL] [Abstract][Full Text] [Related]
10. Renal epithelial neoplasms: the diagnostic implications of electron microscopic study in 55 cases.
Krishnan B; Truong LD
Hum Pathol; 2002 Jan; 33(1):68-79. PubMed ID: 11823975
[TBL] [Abstract][Full Text] [Related]
11. Expression of the Na+/K+-transporting ATPase gamma subunit FXYD2 in renal tumors.
Gaut JP; Crimmins DL; Lockwood CM; McQuillan JJ; Ladenson JH
Mod Pathol; 2013 May; 26(5):716-24. PubMed ID: 23196795
[TBL] [Abstract][Full Text] [Related]
12. Loss of Nuclear BAP1 Expression Is Associated with High WHO/ISUP Grade in Clear Cell Renal Cell Carcinoma.
Wi YC; Moon A; Jung MJ; Kim Y; Bang SS; Jang K; Paik SS; Shin SJ
J Pathol Transl Med; 2018 Nov; 52(6):378-385. PubMed ID: 30269473
[TBL] [Abstract][Full Text] [Related]
13. NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.
Georgescu MM; Cote G; Agarwal NK; White CL
Neoplasia; 2014 Apr; 16(4):365-74.e1-2. PubMed ID: 24862762
[TBL] [Abstract][Full Text] [Related]
14. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
15. NHERF1/EBP50 is a new marker in colorectal cancer.
Hayashi Y; Molina JR; Hamilton SR; Georgescu MM
Neoplasia; 2010 Dec; 12(12):1013-22. PubMed ID: 21170265
[TBL] [Abstract][Full Text] [Related]
16. Histological reclassification, histochemical characterization and c-kit immunoexpression in renal cell carcinoma.
Rekha PR; Rajendiran S; Rao S; Shroff S; Joseph LD; Prathiba D
Indian J Urol; 2008 Jul; 24(3):343-7. PubMed ID: 19468465
[TBL] [Abstract][Full Text] [Related]
17. The enteropathogenic Escherichia coli type III secretion system effector Map binds EBP50/NHERF1: implication for cell signalling and diarrhoea.
Simpson N; Shaw R; Crepin VF; Mundy R; FitzGerald AJ; Cummings N; Straatman-Iwanowska A; Connerton I; Knutton S; Frankel G
Mol Microbiol; 2006 Apr; 60(2):349-63. PubMed ID: 16573685
[TBL] [Abstract][Full Text] [Related]
18. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.
Tickoo SK; Amin MB; Linden MD; Zarbo RJ
Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210
[TBL] [Abstract][Full Text] [Related]
19. Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification.
Brunelli M; Erdini F; Cima L; Eccher A; Fioravanzo A; Gobbo S; Segala D; Ghimenton C; Mazzoleni G; Munari E; Carella R; Martignoni G
Appl Immunohistochem Mol Morphol; 2018; 26(5):316-323. PubMed ID: 27556823
[TBL] [Abstract][Full Text] [Related]
20. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma.
Wang HY; Mills SE
Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]